Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Heirman, Carlo" or (type any "bookEditor issueEditor" and editor="Heirman, Carlo")

Add to list
- Journal Article
- A1
- open access
Development of the nanobody display technology to target lentiviral vectors to antigen-presenting cells

Cleo Goyvaerts, Kurt De Groeve, Jozef Dingemans, Sandra Van Lint (UGent) , Lander Robays, Carlo Heirman, J Reiser, Kris Thielemans, Patrick De Baetselier, Geert Raes, et al.

(2012) GENE THERAPY. 19(12). p.1133-1140
Add to list
Preclinical evaluation of TriMix and antigen mRNA-based anti-tumor therapy

Sandra Van Lint (UGent) , Cleo Goyvaerts, Sarah Maenhout, Lode Goethals, Aurélie Disy, Daphné Benteyn, Joeri Pen, Aude Bonehill, Carlo Heirman, Karine Breckpot, et al.

(2012) CANCER RESEARCH. 72(7). p.1661-1671
Add to list
Large double copy vectors are functional but show a size-dependent decline in transduction efficiency

Tomas J Bos, Sandra Van Lint (UGent) , Carlo Heirman and Karin Vanderkerken

(2010) JOURNAL OF BIOTECHNOLOGY. 150(1). p.37-40
Add to list
Attenuated Expression of A20 Markedly Increases the Efficacy of Double-Stranded RNA-Activated Dendritic Cells As an Anti-Cancer Vaccine

Karine Breckpot, Cindy Aerts-Toegaert, Carlo Heirman, Uschi Peeters, Rudi Beyaert (UGent) , Joeri L Aerts and Kris Thielemans

(2009) JOURNAL OF IMMUNOLOGY. 182(2). p.860-870
Add to list
Activation of immature monocyte-derived dendritic cells after transduction with high doses of lentiviral vectors

Karine Breckpot, Perpetua Emeagi, Melissa Dullaers (UGent) , Annelies Michiels, Carlo Heirman and Kris Thielemans

(2007) HUMAN GENE THERAPY. 18(6). p.536-546

← Previous

Academic Bibliography

Development of the nanobody display technology to target lentiviral vectors to antigen-presenting cells

Preclinical evaluation of TriMix and antigen mRNA-based anti-tumor therapy

Large double copy vectors are functional but show a size-dependent decline in transduction efficiency

Attenuated Expression of A20 Markedly Increases the Efficacy of Double-Stranded RNA-Activated Dendritic Cells As an Anti-Cancer Vaccine

Activation of immature monocyte-derived dendritic cells after transduction with high doses of lentiviral vectors

Contents

Support

Contact